Form 8-K - Current report:
SEC Accession No. 0000950170-25-111586
Filing Date
2025-08-27
Accepted
2025-08-27 08:08:38
Documents
11
Period of Report
2025-08-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mnkd-20250824.htm   iXBRL 8-K 49222
2 EX-10.1 mnkd-ex10_1.htm EX-10.1 74803
  Complete submission text file 0000950170-25-111586.txt   239914

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT mnkd-20250824.xsd EX-101.SCH 25053
13 EXTRACTED XBRL INSTANCE DOCUMENT mnkd-20250824_htm.xml XML 4733
Mailing Address 1 CASPER STREET DANBURY CT 06810
Business Address 1 CASPER STREET DANBURY CT 06810 818-661-5000
MANNKIND CORP (Filer) CIK: 0000899460 (see all company filings)

EIN.: 133607736 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50865 | Film No.: 251259816
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)